ATN Innovation Summit sessions are now on demand.
Every keynote, panel, and fireside chat are now streaming in the video library.
Abbott is one of several firms targeting wellness enthusiasts with a CGM that can be used by non-diabetics to track metabolic health.
Allez Health has raised $60 million in a Series A for its continuous glucose monitoring (CGM) biosensor platform for connected digital health platforms.
Sign Up to Our Newsletter
